Book a Discovery Call →
INSIGHTS

Insights.

Market intelligence, strategic analysis, and operator perspectives on health innovation in Europe. Published weekly. Subscribers receive content the week it is written. Website editions follow a month later.

VITAL SIGNS

Real-time intelligence for health innovation leaders.

Sector intelligence across MedTech, HealthTech, AI in Healthcare, and AI Drug Discovery, with a quarterly BioTech review. A new edition publishes every week; each sector runs bi-weekly. Subscribers receive editions the week they are published. Website versions follow two weeks later.

MedTechHealthTechAI HealthcareAI Drug DiscoveryBioTech
Subscribe to Vital Signs →
FILTER
PERSPECTIVE

AI Drug Discovery: What's the Deal?

AI has largely solved drug discovery's chemistry problem, yet no AI-discovered drug has been approved. The value was never in the molecule.

JUN 25, 2026 · 9 MIN
AI in HealthcareDrug DiscoveryBiotech
Read →
GET HEALTHSEED INTELLIGENCE

In your inbox, the week it is written.

Choose the editions that matter to your business.

Which editions?